Tower Research Capital LLC (TRC) - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 61 filers reported holding GALENA BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q2 2017$20,000
-41.2%
35,078
-37.3%
0.00%
-33.3%
Q1 2017$34,000
+70.0%
55,949
+441.1%
0.00%
+50.0%
Q4 2016$20,00010,3390.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
EQUITEC SPECIALISTS, LLC 358,600$696,0000.17%
ARXIS SECURITIES LLC 13,039$25,0000.03%
EQUITEC SPECIALISTS, LLC 65,600$127,0000.03%
Acrospire Investment Management LLC 13,100$25,0000.01%
Virtu KCG Holdings LLC 60,313$117,0000.00%
INTEGRAL DERIVATIVES, LLC 72,200$140,0000.00%
SABBY MANAGEMENT, LLC 23,298$45,0000.00%
WOLVERINE TRADING, LLC 229,400$445,0000.00%
Tower Research Capital LLC (TRC) 10,339$20,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,030,800$2,000,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders